Plasma proteomic profiling has further demonstrated that AKI in COVID-19 involves tubular injury, hemodynamic perturbation, neutrophil activation, and inflammatory responses, as evidenced by elevated NGAL and other markers (43). The gene discussed is LCN2; the disease is acute kidney injury.